2603.00170 Hypothesis-Driven Agent Workflow for AI Drug Discovery
This paper introduces a novel Hypothesis-Driven Agent Workflow designed to enhance the rigor and strategic foresight in AI Drug Discovery (AIDD) projects. Leveraging the "New Drug Value Assessment Model 3.